Health Care: Drugs

Cell Therapeutics Inc. (CTIC: NASDAQ)

$3.07 n/a | n/a%
04/17/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 3.07
52 Week High 4.25
52 Week Low 0.97
Avg. Daily Vol. (Mil) 5.50
Beta (3 year) 1.51
Share Related Items
Mkt Cap (Mil) 459.33
Shares Out (Mil) 149.64
Float (Mil) 124.31
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.60
Current Ratio 4.00
LT Debt/ Equity 0.22
Total Debt / Equity 0.29
Valuation Ratios
Price Earnings n.a.
Price/Sales 13.25
Price/Book 10.17
Price/Cash Flow -9.40
Per Share Data
Earnings -0.43
Sales 0.23
Book Value 0.30
Cash Flow -0.33
Business Summary
Cell Therapeutics, Inc., is a biopharmaceutical company focused on the acquisition, development and commercialization of less toxic and more effective ways to treat cancer.
General Information
3101 Western Avenue
Suite 600
Seattle, WA 98121
www.celltherapeutics.com
Industry : Drugs
Sector: Health Care
Employees: 106
CEO: Dr. James A. Bianco,M.D.
Short Interest
Current Month (Mil) 15.35
Previous Month (Mil) 10.34
Short Interest Ratio (Days) 2.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -46.50
Return on Investments -78.70
Profitability
Gross Margin 99.60
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CTIC

Latest CTIC Headlines from TheStreet

More Financial News for CTIC

Press Releases for CTIC

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter